133 related articles for article (PubMed ID: 25620067)
21. Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines.
Affram K; Udofot O; Agyare E
Integr Cancer Sci Ther; 2015; 2(2):133-142. PubMed ID: 26090123
[TBL] [Abstract][Full Text] [Related]
22. Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules.
Liang K; Ricco R; Doherty CM; Styles MJ; Bell S; Kirby N; Mudie S; Haylock D; Hill AJ; Doonan CJ; Falcaro P
Nat Commun; 2015 Jun; 6():7240. PubMed ID: 26041070
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Ma J; Fang B; Zeng F; Ma C; Pang H; Cheng L; Shi Y; Wang H; Yin B; Xia J; Wang Z
Oncotarget; 2015 Jan; 6(3):1740-9. PubMed ID: 25638153
[TBL] [Abstract][Full Text] [Related]
24. Triggering mitophagy with far-red fluorescent photosensitizers.
Hsieh CW; Chu CH; Lee HM; Yuan Yang W
Sci Rep; 2015 May; 5():10376. PubMed ID: 26022357
[TBL] [Abstract][Full Text] [Related]
25. Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report.
Lockhart NR; Waddell JA; Schrock NE
J Oncol Pharm Pract; 2016 Jun; 22(3):528-32. PubMed ID: 25670260
[TBL] [Abstract][Full Text] [Related]
26. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
Wang YH; Sui YN; Yan K; Wang LS; Wang F; Zhou JH
Oncol Rep; 2015 Apr; 33(4):1699-706. PubMed ID: 25647019
[TBL] [Abstract][Full Text] [Related]
27. Peptide nucleic acid-zirconium coordination nanoparticles.
Öztürk Ö; Lessl AL; Höhn M; Wuttke S; Nielsen PE; Wagner E; Lächelt U
Sci Rep; 2023 Aug; 13(1):14222. PubMed ID: 37648689
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of three synergistic chemotherapeutics in a core-shell nanoscale coordination polymer for the treatment of pancreatic cancer.
Jiang X; Lee MJ; Luo T; Tillman L; Lin W
Biomaterials; 2023 Oct; 301():122235. PubMed ID: 37441902
[TBL] [Abstract][Full Text] [Related]
29. Platinum-based combination nanomedicines for cancer therapy.
Li Y; Lin W
Curr Opin Chem Biol; 2023 Jun; 74():102290. PubMed ID: 36989943
[TBL] [Abstract][Full Text] [Related]
30. A Three-in-One Nanoscale Coordination Polymer for Potent Chemo-Immunotherapy.
Liu J; Jiang X; Feng X; Lee MJ; Li Y; Mao J; Weichselbaum RR; Lin W
Small Methods; 2023 May; 7(5):e2201437. PubMed ID: 36638256
[TBL] [Abstract][Full Text] [Related]
31. Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview.
Alshememry AK; Alsaleh NB; Alkhudair N; Alzhrani R; Alshamsan A
Front Pharmacol; 2022; 13():933457. PubMed ID: 36091785
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in metallopolymer-based drug delivery systems.
Dzhardimalieva GI; Rabinskiy LN; Kydralieva KA; Uflyand IE
RSC Adv; 2019 Nov; 9(63):37009-37051. PubMed ID: 35539076
[TBL] [Abstract][Full Text] [Related]
33. Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.
Han H; Li S; Zhong Y; Huang Y; Wang K; Jin Q; Ji J; Yao K
Asian J Pharm Sci; 2022 Jan; 17(1):35-52. PubMed ID: 35261643
[TBL] [Abstract][Full Text] [Related]
34. Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer.
Tarannum M; Hossain MA; Holmes B; Yan S; Mukherjee P; Vivero-Escoto JL
Small; 2022 Jan; 18(2):e2104449. PubMed ID: 34758094
[TBL] [Abstract][Full Text] [Related]
35. Could Cisplatin Loading on Biosynthesized Silver Nanoparticles Improve Its Therapeutic Efficacy on Human Prostate Cancer Cell Line and Reduce Its In Vivo Nephrotoxic Effects?
El-Sheikh SMA; Edrees N; El-Sayed H; Khamis T; Arisha AH; Metwally MMM; Eleiwa NZ; Galal AAA
Biol Trace Elem Res; 2022 Feb; 200(2):582-590. PubMed ID: 33759109
[TBL] [Abstract][Full Text] [Related]
36. Engineering Prodrug Nanomedicine for Cancer Immunotherapy.
Yang B; Gao J; Pei Q; Xu H; Yu H
Adv Sci (Weinh); 2020 Dec; 7(23):2002365. PubMed ID: 33304763
[TBL] [Abstract][Full Text] [Related]
37. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer.
Zhou Y; Zhou W; Chen X; Wang Q; Li C; Chen Q; Zhang Y; Lu Y; Ding X; Jiang C
Acta Pharm Sin B; 2020 Aug; 10(8):1563-1575. PubMed ID: 32963950
[TBL] [Abstract][Full Text] [Related]
39. Design of Targeted Nanostructured Coordination Polymers (NCPs) for Cancer Therapy.
Novio F
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751178
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels.
Du J; Gu J; Li J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
